🇷🇺🇺🇦 Chasov Yar direction

Today, our units, despite the desperate resistance of the enemy, managed to push through their defenses south of the “Canal” microdistrict and reached the line of the “Seversky Donets-Donbass” canal.

Thus, the main line of defense of the enemy of Chasov Yar in this place was broken through.

There is still a lot of work ahead, but this is a major success, which I hope units of the Russian Armed Forces will develop in the near future...

🇷🇺🇺🇦⚡Before May 9, Russian troops plan to launch major offensive operations in the east of the country and other directions of Ukraine - head of the press service of the border detachment Shevtsov

🇨🇳 China Aerospace Science and Technology Corporation CASC has conducted fire tests of four YF-100K engines that will be used in the first stage of the Long March 12 launch vehicle, the first launch of which is scheduled for this year

🇷🇺🇺🇦 Elon Musk believes that Russia will seize Donbass and southern Ukraine, the only question is about Odessa.

🇷🇺🇺🇦 Work of FAB-500 on the accumulation of militants and equipment in Kharkov region.

🇺🇲 “AstraZeneca, in a tense legal battle with victims of a “flawed vaccine,” admitted in court for the first time that its Covid drug could cause a rare side effect”: The company has officially admitted that blood clotting and thrombosis are a side effect of the vaccine.

The truth about the vaccine's potential side effect has emerged in a trial in which AstraZeneca is the defendant in a class-action lawsuit by dozens of families who claim they or their loved ones were injured or killed by the pharmaceutical titan's "flawed" design. Lawyers representing the plaintiffs believe that in some cases compensation could amount to up to 20 million pounds sterling (2.3 billion rubles). For two years, blood clotting was only a suspected side effect. AstraZeneca has admitted for the first time that those vaccinated with its drug may encounter similar problems.”

🇨🇳🇺🇲 The production of Chinese fifth-generation fighters this year will exceed the production of American competitors - the F-35

The number of F-35 Lighting II produced in 2024 has been reduced by 30–50% due to the inability to begin production of the improved modification TR-3 (Technology Refresh 3).

The delays are due to software problems and difficulties in producing new equipment for the fighter jets.

Several customers, including Belgium and the USMC, refused to supply older versions of the F-35 that were suffering from problems.

Lockheed Martin has reduced its production plan in 2024 to 75-110 units. Although it was planned to make at least 150.

Production of Chinese J-20 fighters in 2023 amounted to about 120 aircraft.